Advertisement

Topics

Tagrisso (osimertinib) Receives FDA Full Approval

20:03 EDT 30 Mar 2017 | Drugs.com

31 March 2017 -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted full approval for Tagrisso (osimertinib) 80mg once-daily tablets, for the treatment of patients with metastatic epidermal growth factor receptor...

Original Article: Tagrisso (osimertinib) Receives FDA Full Approval

NEXT ARTICLE

More From BioPortfolio on "Tagrisso (osimertinib) Receives FDA Full Approval"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...